DexCom shares what happened during their earnings call for the third quarter of 2026.

Oct 29, 2026, 5:52 PM ETResultsRead the original at Benzinga

Good for DXCM

DexCom grew sales, gained U.S. share, and expanded its products and factory capacity. Broader coverage for some patients is still only a possibility, but the reported business gains support a brighter outlook.

DXCM · DexCom

AI read · Good for DXCM

The AI's read

Sales gains and U.S. share wins suggest more customers are choosing DexCom’s glucose monitors. New products and added factory capacity support that progress. Broader coverage for people with type 2 diabetes who do not use insulin still depends on a CMS decision that has not been announced.

Get alerts for DXCM

Follow DexCom (DXCM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DXCM

Free on the App Store and Google Play, or on the web.